BB-102 (Tianjin Hi-Tech)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBB-102 (Tianjin Hi-Tech)
Drug Alias Nameoncolytic adenovirus therapy expressing p53 + GM-CSF + B7.1 (Tianjin Hi-Tech/The Institute of Radiation Medicine)oncolytic adenovirus therapy expressing p53 + GM-CSF + CD28 costimulator (Tianjin Hi-Tech/The Institute of Radiation Medicine)BB-102 (Tianjin Hi-Tech)
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionCluster of differentiation 80 modulatorsGranulocyte-macrophage colony-stimulating factor receptor stimulantsTumor protein p53 modulators +[4] 
TargetsGranulocyte-macrophage colony-stimulating factor receptorCluster of differentiation 80T-cell-specific surface glycoprotein CD28 +[4] 
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaPending
Originator CompaniesInstitute Of Radiation And Radiation Medicine, Chinese Academy Of Military Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTianjin Hi-Tech Medical Technology Development Co LtdInstitute Of Radiation And Radiation Medicine, Chinese Academy Of Military Medical Sciences
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A